Added to YB: 2026-07-30
Pitch date: 2026-07-28
PFE [neutral]
Pfizer Inc.
-0.79%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
Market Cap
$143.9B
Pitch Price
$25.35
Price Target
N/A
Dividend
6.81%
EV/EBITDA
7.42
P/E
19.27
EV/Sales
3.09
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Pfizer Looks Cheap And Safe. So Why Is It Still a Poor Investment?
PFE (overview): Looks cheap at 18x P/E, high dividend, but a 'Valuation Comfort Trap.' Post-COVID rev fell $100B→$63B, EBITDA margins swung 16-46%, FCF ranged -$39B to +$30B. Net debt doubled post-Seagen, Net debt/EBITDA peaked 7.1x in '23. Low multiple reflects unpredictable earnings, not hidden value.
Read full article (4 min)